Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 1 Study of Cotadutide in Japanese Obese Subjects With Type 2 Diabetes Mellitus
jRCT2080225031Phase 1Completed
- Sponsor
- AstraZeneca
- Start
- Jan 2020
- Modality
- Peptides
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial in type 2 diabetes mellitus (T2DM) and obesity comparing Cotadutide with Placebo (2 arms). Primary endpoints: Safety and tolerability of cotadutide, Pharmacokinetics of cotadutide and 1 more. Started Jan 2020; status: completed.
02
Drugs
cotadutide
03
Conditions
type 2 diabetes mellitus (T2DM)obesity
Beyond the preview
Go deeper on jRCT2080225031.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080225031.